Management dont seem too confident in holding a large % of this company. Roby Zomer states that their operations are in Europe and would like to be listed on LSE for capital reason and exposure, but has been raising money in Aus since 2015/2016. Makes you wonder.
I suggest watching interviews with Roby Zomer February 2021 for recent rundown on MXC.
We want a listing in proximity to our operations: MGC Pharmaceuticals CEO - YouTube
MGC Pharmaceuticals get set for LSE debut as first medicinal cannabis company listed on main market - YouTube
LSE listing, page-59
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
-0.005(0.93%) |
Mkt cap ! $25.89M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 53.5¢ | 46.0¢ | $43.89K | 90.60K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4790 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 85 | 1 |
View Market Depth
| Last trade - 13.02pm 03/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |